{"count": 8, "results": [{"_id": "34768528", "pmid": 34768528, "pmcid": "PMC8584884", "title": "Carotid Artery Temperature Reduction with Statin Therapy in Patients with Familial Hyperlipidemia Syndromes", "journal": "J Clin Med", "authors": ["Benetos G", "Galanakos S", "Koutagiar I", "Skoumas I", "Oikonomou G", "Drakopoulou M", "Karmpalioti M", "Katsi V", "Tsioufis C", "Toutouzas K"], "date": "2021-10-27T00:00:00Z", "doi": "10.3390/jcm10215008", "meta_date_publication": "2021 Oct 27", "meta_volume": "10", "meta_issue": "21", "meta_pages": "", "score": 50264.63, "text_hl": "Carotid artery temperatures were significantly reduced at 6 months in @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@FH@@@ @SPECIES_9606 @@@patients@@@ who received hypolipidemic treatment (0.83 +- 0.34 versus 0.63 +- 0.24  C, p = 0.004 for @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, 1.00 +- 0.38 versus 0.69 +- 0.23  C, p < 0.001 for @CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination @CHEMICAL_MESH:D000069499 @@@simvastatin + ezetimibe@@@), but no change was recorded in controls (0.72 +- 0.26 versus 0.70 +- 0.26  C, p = 0.86). ", "citations": {"NLM": "Benetos G, Galanakos S, Koutagiar I, Skoumas I, Oikonomou G, Drakopoulou M, Karmpalioti M, Katsi V, Tsioufis C, Toutouzas K. Carotid Artery Temperature Reduction with Statin Therapy in Patients with Familial Hyperlipidemia Syndromes J Clin Med. 2021 Oct 27;10(21):. PMID: 34768528", "BibTeX": "@article{34768528, title={Carotid Artery Temperature Reduction with Statin Therapy in Patients with Familial Hyperlipidemia Syndromes}, author={Benetos G and Galanakos S and Koutagiar I and Skoumas I and Oikonomou G and Drakopoulou M and Karmpalioti M and Katsi V and Tsioufis C and Toutouzas K}, journal={J Clin Med}, volume={10}, number={21}}"}}, {"_id": "8847874", "pmid": 8847874, "title": "Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.", "journal": "J Cardiovasc Pharmacol", "authors": ["Steinmetz A", "Schwartz T", "Hehnke U", "Kaffarnik H"], "date": "1996-04-01T00:00:00Z", "doi": "10.1097/00005344-199604000-00016", "meta_date_publication": "1996 Apr", "meta_volume": "27", "meta_issue": "4", "meta_pages": "563-70", "score": 50082.273, "text_hl": "Multicenter comparison of micronized @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_9606 @@@patients@@@ with primary @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@type IIA or IIB hyperlipoproteinemia@@@.", "citations": {"NLM": "Steinmetz A, Schwartz T, Hehnke U, Kaffarnik H. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia. J Cardiovasc Pharmacol. 1996 Apr;27(4):563-70. PMID: 8847874", "BibTeX": "@article{8847874, title={Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.}, author={Steinmetz A and Schwartz T and Hehnke U and Kaffarnik H}, journal={J Cardiovasc Pharmacol}, volume={27}, number={4}, pages={563-70}}"}}, {"_id": "3402470", "pmid": 3402470, "title": "Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia.", "journal": "Eur Heart J", "authors": ["Mölgaard J", "von Schenck H", "Olsson AG"], "date": "1988-05-01T00:00:00Z", "doi": "10.1093/oxfordjournals.eurheartj.a062541", "meta_date_publication": "1988 May", "meta_volume": "9", "meta_issue": "5", "meta_pages": "541-51", "score": 50081.758, "text_hl": "The effect of 24 weeks of treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, a new HMG coenzyme A reductase inhibitor (dosages of 20 and 40 mg day-1) on serum @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@, lipoprotein and @GENE_APOA1 @GENE_335 @@@apolipoprotein A-I and B@@@ concentrations as well as safety parameters and subjective side effects were studied in 11 @SPECIES_9606 @@@patients@@@ with familial @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@(FH@@@) and 10 @SPECIES_9606 @@@patients@@@ with polygenic hypercholesterolaemia (P-HC). ", "citations": {"NLM": "Mölgaard J, von Schenck H, Olsson AG. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia. Eur Heart J. 1988 May;9(5):541-51. PMID: 3402470", "BibTeX": "@article{3402470, title={Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia.}, author={Mölgaard J and von Schenck H and Olsson AG}, journal={Eur Heart J}, volume={9}, number={5}, pages={541-51}}"}}, {"_id": "11181283", "pmid": 11181283, "title": "[Influence of FH Valencia 1 and 2 mutations of the LDL receptor gene on the response to simvastatin in subjects with molecularly defined heterozygous familial hypercholesterolemia in Spain].", "journal": "Med Clin (Barc)", "authors": ["Real JT", "Chaves FJ", "Civera M", "García-García AB", "Ascaso JF", "Armengod ME", "Carmena R"], "date": "2001-01-27T00:00:00Z", "doi": "10.1016/s0025-7753(01)71731-9", "meta_date_publication": "2001 Jan 27", "meta_volume": "116", "meta_issue": "3", "meta_pages": "81-5", "score": 50079.363, "text_hl": "SUBJECTS AND METHOD: A randomised clinical trial with no control group, with 20 mg/day of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was conducted in 27 genetically diagnosed @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@FH@@@ subjects (11 male) from 8 @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@FH@@@ families, randomly selected from 30 @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@FH@@@ families with a molecular diagnosis. ", "citations": {"NLM": "Real JT, Chaves FJ, Civera M, García-García AB, Ascaso JF, Armengod ME, Carmena R. [Influence of FH Valencia 1 and 2 mutations of the LDL receptor gene on the response to simvastatin in subjects with molecularly defined heterozygous familial hypercholesterolemia in Spain]. Med Clin (Barc). 2001 Jan 27;116(3):81-5. PMID: 11181283", "BibTeX": "@article{11181283, title={[Influence of FH Valencia 1 and 2 mutations of the LDL receptor gene on the response to simvastatin in subjects with molecularly defined heterozygous familial hypercholesterolemia in Spain].}, author={Real JT and Chaves FJ and Civera M and García-García AB and Ascaso JF and Armengod ME and Carmena R}, journal={Med Clin (Barc)}, volume={116}, number={3}, pages={81-5}}"}}, {"_id": "9571327", "pmid": 9571327, "title": "Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.", "journal": "Diabetes Care", "authors": ["Tikkanen MJ", "Laakso M", "Ilmonen M", "Helve E", "Kaarsalo E", "Kilkki E", "Saltevo J"], "date": "1998-04-01T00:00:00Z", "doi": "10.2337/diacare.21.4.477", "meta_date_publication": "1998 Apr", "meta_volume": "21", "meta_issue": "4", "meta_pages": "477-81", "score": 50073.32, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ produced 15-30% reductions in @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglyceride@@@ levels in @DISEASE_Hodgkin_Disease @DISEASE_MESH:D006689 @@@CHL@@@ but no change in @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@IHC@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Tikkanen MJ, Laakso M, Ilmonen M, Helve E, Kaarsalo E, Kilkki E, Saltevo J. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study. Diabetes Care. 1998 Apr;21(4):477-81. PMID: 9571327", "BibTeX": "@article{9571327, title={Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.}, author={Tikkanen MJ and Laakso M and Ilmonen M and Helve E and Kaarsalo E and Kilkki E and Saltevo J}, journal={Diabetes Care}, volume={21}, number={4}, pages={477-81}}"}}, {"_id": "2483819", "pmid": 2483819, "title": "Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.", "journal": "Eicosanoids", "authors": ["Schrör K", "Löbel P", "Steinhagen-Thiessen E"], "date": "1989-01-01T00:00:00Z", "meta_date_publication": "1989", "meta_volume": "2", "meta_issue": "1", "meta_pages": "39-45", "score": 50071.547, "text_hl": "Twelve @SPECIES_9606 @@@patients@@@ suffering from @DISEASE_Hyperlipoproteinemia_Type_II @DISEASE_MESH:D006938 @@@familial hyperlipoproteinemia type IIa@@@ (@<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@FH@@@) were treated for 8 months with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (20-40 mg/day) and compared with 10 untreated @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@FH@@@ @SPECIES_9606 @@@patients@@@ and 10 untreated normocholesterolemic subjects. ", "citations": {"NLM": "Schrör K, Löbel P, Steinhagen-Thiessen E. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia. Eicosanoids. 1989;2(1):39-45. PMID: 2483819", "BibTeX": "@article{2483819, title={Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.}, author={Schrör K and Löbel P and Steinhagen-Thiessen E}, journal={Eicosanoids}, volume={2}, number={1}, pages={39-45}}"}}, {"_id": "10225769", "pmid": 10225769, "title": "The familial hypercholesterolemia regression study: a randomized comparison of therapeutic reduction of both low-density lipoprotein and lipoprotein(a) versus low-density lipoprotein alone.", "journal": "Ther Apher", "authors": ["Kitano Y", "Thompson GR"], "date": "1997-05-01T00:00:00Z", "doi": "10.1111/j.1744-9987.1997.tb00039.x", "meta_date_publication": "1997 May", "meta_volume": "1", "meta_issue": "2", "meta_pages": "187-90", "score": 50060.83, "text_hl": "To ascertain whether reduction of both LDL and Lp(a) is more advantageous than reduction of LDL alone, @SPECIES_9606 @@@patients@@@ with heterozygous @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@FH@@@ and @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@CHD@@@ were selected randomly to receive either LDL apheresis fortnightly plus @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg/day or @CHEMICAL_Colestipol @CHEMICAL_MESH:D003084 @@@colestipol@@@ 20 g plus @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg/day. ", "citations": {"NLM": "Kitano Y, Thompson GR. The familial hypercholesterolemia regression study: a randomized comparison of therapeutic reduction of both low-density lipoprotein and lipoprotein(a) versus low-density lipoprotein alone. Ther Apher. 1997 May;1(2):187-90. PMID: 10225769", "BibTeX": "@article{10225769, title={The familial hypercholesterolemia regression study: a randomized comparison of therapeutic reduction of both low-density lipoprotein and lipoprotein(a) versus low-density lipoprotein alone.}, author={Kitano Y and Thompson GR}, journal={Ther Apher}, volume={1}, number={2}, pages={187-90}}"}}, {"_id": "11849659", "pmid": 11849659, "title": "Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia.", "journal": "Atherosclerosis", "authors": ["Vohl MC", "Szots F", "Lelièvre M", "Lupien PJ", "Bergeron J", "Gagné C", "Couture P"], "date": "2002-02-01T00:00:00Z", "doi": "10.1016/s0021-9150(01)00584-6", "meta_date_publication": "2002 Feb", "meta_volume": "160", "meta_issue": "2", "meta_pages": "361-8", "score": 50057.895, "text_hl": "A randomized, double-blind, placebo-controlled clinical trial with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, an @GENE_HMGCR @GENE_3156 @@@HMG CoA reductase@@@ inhibitor, was conducted in 63 adolescents (47 treated versus 17 controls) with heterozygous @<m>DISEASE_143890</m> @DISEASE_OMIM:143890 @@@FH@@@. ", "citations": {"NLM": "Vohl MC, Szots F, Lelièvre M, Lupien PJ, Bergeron J, Gagné C, Couture P. Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia. Atherosclerosis. 2002 Feb;160(2):361-8. PMID: 11849659", "BibTeX": "@article{11849659, title={Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia.}, author={Vohl MC and Szots F and Lelièvre M and Lupien PJ and Bergeron J and Gagné C and Couture P}, journal={Atherosclerosis}, volume={160}, number={2}, pages={361-8}}"}}]}